CheckMate 592: A phase II exploratory study of biomarkers associated with the efficacy of first-line nivolumab (nivo) plus ipilimumab (ipi) in patients (pts) with stage IV or recurrent NSCLC
Gettinger, S., Beck, T., Yang, X., Telivala, B., Morgensztern, D., Velcheti, V., Ramalingam, S.S., Schalper, K., Dajee, M., Ranck, A., Yang, R., Spigel, D.R.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
365P - Measures of functional status in adults aged ≥70 years with advanced breast cancer (ABC) receiving palbociclib (PAL) combination therapy in POLARIS
Karuturi, M.S., Blum, J.L., Wallmark, J., McCune, S., Lakhanpal, S., Telivala, B., Tsai, M., Rakowski, T., Bardia, A., Cappelleri, J.C., Richardson, E., Wang, Y., Tripathy, D.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Measures of functional status in adults aged ≥70 years with advanced breast cancer (ABC) receiving palbociclib (PAL) combination therapy in POLARIS
Karuturi, M.S., Blum, J.L., Wallmark, J., McCune, S., Lakhanpal, S., Telivala, B., Tsai, M., Rakowski, T., Bardia, A., Cappelleri, J.C., Richardson, E., Wang, Y., Tripathy, D.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1503TiPCheckMate 592: A phase II exploratory study of biomarkers associated with the efficacy of first-line nivolumab (nivo) plus ipilimumab (ipi) in patients (pts) with stage IV or recurrent NSCLC
Gettinger, S, Beck, T, Yang, X, Telivala, B, Morgensztern, D, Velcheti, V, Ramalingam, S S, Schalper, K, Dajee, M, Ranck, A, Yang, R, Spigel, D R
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
365PMeasures of functional status in adults aged ≥70 years with advanced breast cancer (ABC) receiving palbociclib (PAL) combination therapy in POLARIS
Karuturi, M S, Blum, J L, Wallmark, J, McCune, S, Lakhanpal, S, Telivala, B, Tsai, M, Rakowski, T, Bardia, A, Cappelleri, J C, Richardson, E, Wang, Y, Tripathy, D
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Luminespib plus pemetrexed in patients with non-squamous non-small cell lung cancer
Noor, Zorawar S., Goldman, Jonathan W., Lawler, William E., Telivala, Bijoy, Braiteh, Fadi, DiCarlo, Brian A., Kennedy, Kathleen, Adams, Brad, Wang, Xiaoyan, Jones, Benjamin, Slamon, Dennis J., Garon, Edward B.
Published in Lung cancer (Amsterdam, Netherlands) (01.09.2019)
Published in Lung cancer (Amsterdam, Netherlands) (01.09.2019)
Get full text
Journal Article
P2.13-39 A Phase Ib Trial of the HSP90 Inhibitor AUY922 in Combination with Pemetrexed in Metastatic Non-Squamous, Non-Small Cell Lung Cancer Patients
Noor, Z., Goldman, J.W., Lawler, W., Melancon, D., Telivala, B., Braiteh, F., Dicarlo, B., Kennedy, K., Martinez, D., Adams, B., Wang, X., Jones, B., Garon, E.
Published in Journal of thoracic oncology (01.10.2018)
Published in Journal of thoracic oncology (01.10.2018)
Get full text
Journal Article
2MO First-line (1L) nivolumab (NIVO) + ipilimumab (IPI) in metastatic non-small cell lung cancer (mNSCLC): Clinical outcomes and biomarker analyses from CheckMate 592
Gettinger, S., Schenker, M., De Langen, J., Fischer, J.R., Morgensztern, D., Ciuleanu, T-E., Beck, T., De Castro Carpeno, J., Schumann, C., Yang, X., Telivala, B., Deschepper, K., Nadal, E., Schalper, K., Spires, T., Balli, D., Nassar, A., Karam, S., Bhingare, A., Spigel, D.R.
Published in Immuno-oncology technology (01.12.2022)
Published in Immuno-oncology technology (01.12.2022)
Get full text
Journal Article